58 min listen
Addressing ART Safety and Tolerability in Transgender Individuals
Addressing ART Safety and Tolerability in Transgender Individuals
ratings:
Length:
18 minutes
Released:
Dec 7, 2022
Format:
Podcast episode
Description
In this episode, Jill Blumenthal, MD, MAS, and Jennifer Cocohoba, PharmD, share how they manage possible antiretroviral (ARV)-associated toxicities in transgender individuals, including:Strategies on how to approach different ARV-related toxicitiesOther factors to consider when assessing possible ARV-related toxicities (eg, weight gain, cardiovascular disease), such as gender-affirming care and nonmedication risk factors (eg, smoking, life stressors)Clinically relevant drug–drug interactions related to HIV and gender-affirming careMethods to reduce barriers to ART adherenceFaculty: Jill Blumenthal, MD, MASAssociate Professor of MedicineInfectious Diseases and Global Public HealthUniversity of California, San DiegoSan Diego, CaliforniaJennifer Cocohoba, PharmDProfessorDepartment of Clinical PharmacyUniversity of California, San FranciscoPharmacistWomen’s HIV ProgramUniversity of California San Francisco Medical CenterSan Francisco, CaliforniaLink to full program:https://bit.ly/3PM3nYeFollow along with the slides at:https://bit.ly/3NpAYI1
Released:
Dec 7, 2022
Format:
Podcast episode
Titles in the series (100)
Virtual ECCVID 2020 Conference – Rapid Recap: Hear insights from Barbara Rath, MD, PhD, HDR, on some of the most important new data reported at the 2020 European Society of Clinical Microbiology and Infectious Diseases Conference on Corona Virus Disease (ECCVID), including information on COVID-19 screening and diagnostics, vaccines, prevention strategies, and therapeutics. by CCO Infectious Disease Podcast